VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 168 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,109 | -31.2% | 3,266,025 | +4.9% | 0.02% | -20.0% |
| Q2 2023 | $20,509 | +2.9% | 3,112,067 | +6.0% | 0.03% | +15.4% |
| Q1 2023 | $19,930 | -6.7% | 2,935,225 | +1.6% | 0.03% | -10.3% |
| Q4 2022 | $21,353 | -99.9% | 2,889,425 | -12.3% | 0.03% | -37.0% |
| Q3 2022 | $32,557,000 | -17.9% | 3,295,233 | -9.4% | 0.05% | -2.1% |
| Q2 2022 | $39,637,000 | +9.2% | 3,636,433 | +13.3% | 0.05% | +9.3% |
| Q1 2022 | $36,289,000 | -28.0% | 3,208,614 | -0.1% | 0.04% | -31.7% |
| Q4 2021 | $50,400,000 | -10.4% | 3,212,214 | -2.1% | 0.06% | -13.7% |
| Q3 2021 | $56,259,000 | -21.0% | 3,282,322 | -0.9% | 0.07% | -18.0% |
| Q2 2021 | $71,218,000 | +28.6% | 3,310,922 | -10.2% | 0.09% | +29.0% |
| Q1 2021 | $55,371,000 | +5.6% | 3,686,480 | -7.6% | 0.07% | +21.1% |
| Q4 2020 | $52,434,000 | +23.9% | 3,990,403 | -8.9% | 0.06% | +35.7% |
| Q3 2020 | $42,320,000 | -12.5% | 4,380,922 | +3.6% | 0.04% | 0.0% |
| Q2 2020 | $48,389,000 | +21.3% | 4,229,822 | +9.9% | 0.04% | +7.7% |
| Q1 2020 | $39,882,000 | -29.6% | 3,849,654 | +11.5% | 0.04% | -11.4% |
| Q4 2019 | $56,666,000 | +33.0% | 3,453,112 | +7.6% | 0.04% | +22.2% |
| Q3 2019 | $42,607,000 | +8.1% | 3,208,340 | +14.7% | 0.04% | +2.9% |
| Q2 2019 | $39,425,000 | -16.5% | 2,798,050 | +9.1% | 0.04% | -18.6% |
| Q1 2019 | $47,191,000 | -28.1% | 2,564,750 | +2.1% | 0.04% | -40.3% |
| Q4 2018 | $65,622,000 | +39.6% | 2,511,350 | +22.6% | 0.07% | +50.0% |
| Q3 2018 | $47,017,000 | -21.2% | 2,048,650 | -38.3% | 0.05% | +45.5% |
| Q2 2018 | $59,663,000 | +115.9% | 3,321,300 | +102.5% | 0.03% | +10.0% |
| Q1 2018 | $27,635,000 | +26.7% | 1,640,050 | +14.3% | 0.03% | +25.0% |
| Q4 2017 | $21,810,000 | +0.0% | 1,434,850 | +17.8% | 0.02% | -7.7% |
| Q3 2017 | $21,807,000 | +21.8% | 1,218,250 | +11.0% | 0.03% | +13.0% |
| Q2 2017 | $17,897,000 | +36.1% | 1,097,950 | +16.9% | 0.02% | +27.8% |
| Q1 2017 | $13,150,000 | +45.1% | 939,250 | +65.3% | 0.02% | +28.6% |
| Q4 2016 | $9,065,000 | +26.1% | 568,350 | +31.5% | 0.01% | +7.7% |
| Q3 2016 | $7,189,000 | +325.4% | 432,050 | +186.0% | 0.01% | +333.3% |
| Q2 2016 | $1,690,000 | -51.5% | 151,050 | -63.8% | 0.00% | -57.1% |
| Q1 2016 | $3,485,000 | +11.0% | 416,900 | +23.6% | 0.01% | 0.0% |
| Q4 2015 | $3,141,000 | +73.2% | 337,390 | +72.9% | 0.01% | +75.0% |
| Q1 2015 | $1,814,000 | -35.4% | 195,100 | -24.0% | 0.00% | -42.9% |
| Q3 2013 | $2,810,000 | -1.8% | 256,600 | -27.5% | 0.01% | -12.5% |
| Q2 2013 | $2,861,000 | – | 354,129 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,581,176 | $60,838,000 | 4.05% |
| ARMISTICE CAPITAL, LLC | 3,548,000 | $47,117,000 | 3.12% |
| Birchview Capital, LP | 80,000 | $1,062,000 | 0.71% |
| 361 CAPITAL LLC | 163,333 | $2,169,000 | 0.40% |
| CADENCE CAPITAL MANAGEMENT LLC | 172,512 | $2,291,000 | 0.32% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 215,936 | $2,868,000 | 0.25% |
| Zebra Capital Management LLC | 15,634 | $208,000 | 0.23% |
| BOOTHBAY FUND MANAGEMENT, LLC | 149,139 | $1,981,000 | 0.18% |
| GLOBEFLEX CAPITAL L P | 48,207 | $640,000 | 0.14% |
| Virtus ETF Advisers LLC | 47,470 | $630,000 | 0.13% |